ATTO

Conviction 0Scan · Tue, Aug 18, 2026

ATTO$22.71+14.35%

ResistanceSupportVol 14Insider buyInsider sell

Aug 5Aug 7Aug 10Aug 12Aug 13Aug 17

Attovia Therapeutics, Inc.Biological Products, (No Diagnostic Substances)

Price22.71

Change+14.35%

Gap-0.05%

Rel volume0.16×

Avg volume852.13K

Avg $ vol17.9M

SMA 20—

SMA 50—

SMA 200—

Price vs 50—

Price vs 200—

MA stack—

50/200 cross—

Supertrend—

RSI (14)—

MACD hist—

MACD cross—

Stoch %K / %D— / —

ADX (14)—

+DI / −DI— / —

RSI divergence—

MACD divergence—

ATR %—

ADR %—

52w high22.71

52w low18.06

From 52w high+0.00%

Above 52w low+25.75%

New 52w highYes

SqueezeOff

Bollinger width—

%B—

Donchian pos—

Donchian high—

Donchian low—

AVWAP (52w high)20.80

vs AVWAP high+9.17%

AVWAP (52w low)18.74

vs AVWAP low+21.17%

OBV trend—

Chaikin MF (20)—

Today vs 20d0.16×

Avg vol (14d)—

Avg vol (20d)852.13K

Avg $ vol (20d)17.9M

Market cap—

RS 3m (vs SPY)—

RS 6m (vs SPY)—

RS line new highYes

Trend template—

Technical rank99.2

1 week+14.47%

1 month—

3 months—

6 months—

1 year—

YTD+3.70%

P/E—

P/B—

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current—

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value—

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryBiological Products, (No Diagnostic Substances)

ExchangeNasdaq

Shares out—

Employees—

Listed—

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank99.2 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirm—

News sentiment—

Congress activity

Disclosed STOCK Act trades in ATTO

All disclosures →

No recent disclosed trades by Congress in ATTO. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ATTO · 6 buys · 4 sells

Insider	Side	Shares	Value	Traded	Filed
GOLDMAN SACHS GROUP INC Insider · Series B Preferred Stock · 2026-08-06	Convert	18.18M	—	2026-08-06	2026-08-13
GOLDMAN SACHS GROUP INC Insider · Series C Preferred Stock · 2026-08-06	Convert	4.45M	—	2026-08-06	2026-08-13
GOLDMAN SACHS GROUP INC Insider · Common Stock · 2026-08-06	Convert	1.96M	—	2026-08-06	2026-08-13
GOLDMAN SACHS GROUP INC Insider · Common Stock · 2026-08-06	Convert	478.5K	—	2026-08-06	2026-08-13
GOLDMAN SACHS GROUP INC Insider · Common Stock · 2026-08-06	Buy	500K	$8.5M	2026-08-06	2026-08-13
WALSH COLIN Director · Common Stock · 2026-08-06	Convert	1.96M	—	2026-08-06	2026-08-13
WALSH COLIN Director · Common Stock · 2026-08-06	Convert	478.5K	—	2026-08-06	2026-08-13
WALSH COLIN Director · Common Stock · 2026-08-06	Buy	500K	$8.5M	2026-08-06	2026-08-13
WALSH COLIN Director · Series B Preferred Stock · 2026-08-06	Convert	18.18M	—	2026-08-06	2026-08-13
WALSH COLIN Director · Series C Preferred Stock · 2026-08-06	Convert	4.45M	—	2026-08-06	2026-08-13

SEC filings

EDGAR filings in ATTO · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.